Form 4: Anterix CEO Scott Lang Receives Equity Grant
Statement of Changes in Beneficial Ownership
Anterix Inc. President and CEO Scott Lang was granted 18,210 restricted stock units and 72,839 stock options on May 20, 2026.
Summary
- Scott Lang, President and CEO of Anterix Inc., received an equity compensation package consisting of 18,210 restricted stock units (RSUs) and 72,839 stock options.
- The RSUs represent a contingent right to receive one share of common stock per unit.
- The stock options have an exercise price of $60.90 per share.
- Both the RSUs and the stock options follow a three-year vesting schedule, with 1/3 vesting on May 20, 2027, and the remainder vesting quarterly through May 20, 2029.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard executive compensation practices rather than a change in company fundamentals.
Positives
- Alignment of executive interests with long-term shareholder value through multi-year vesting schedules.
- Retention of key leadership personnel via equity-based incentives.
Negatives
- Potential for future shareholder dilution upon the exercise of options and vesting of RSUs.
Risks
- Market price volatility affecting the value of the granted equity.
- Performance risk associated with the company's ability to meet strategic goals to justify the exercise price of $60.90.
Future Outlook
The equity grant structure indicates a long-term commitment by the CEO to the company's growth trajectory over the next three years.
Management Comments
- No specific narrative comments were provided in this regulatory filing.
Industry Context
StockSavvy.ai notes that equity grants for C-suite executives are standard practice in the technology and telecommunications sectors to ensure leadership retention and alignment with long-term corporate performance.
Comparison to Industry Standards
- The three-year vesting schedule is consistent with standard corporate governance practices for executive compensation in the U.S. technology sector.
- The use of both RSUs and stock options is a common hybrid approach to balance retention and performance-based incentives.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise of these options and vesting of RSUs.
Next Steps
- Vesting of the first tranche of equity on May 20, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Date of grant for RSUs and stock options. |
| 05/20/2027 | Initial 1/3 vesting date for both RSUs and stock options. |
| 05/20/2029 | Final vesting date for RSUs and stock options. |
| 05/20/2036 | Expiration date for the stock options. |
Keywords
Anterix, ATEX, Executive Compensation, Form 4, Insider Trading, Stock Options, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.